Terumo Corporation Unsponsored ADR (TRUMY)
Summary
Terumo Corporation (TRUMY) Analyst/Investor Day Transcript
Terumo Corporation (TRUMY) Analyst/Investor Day Transcript
Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s Why
Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s share price gapped down before the market opened on Friday. The stock had previously closed at $12.76, but opened at $12.1501. Terumo shares last traded at $12.54, with a volume of 652 shares. Terumo Stock Down 0.8% The firm's 50-day moving average price is $13.96 and its
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
Terumo Corporation Unsponsored ADR (TRUMY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Terumo Corporation Unsponsored ADR ever had a stock split?
Terumo Corporation Unsponsored ADR Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Hikaru Samejima CEO | OTC PINK Exchange | 88156J105 CUSIP |
| JP Country | 30,207 Employees | 30 Mar 2026 Last Dividend | 2 Apr 2014 Last Split | - IPO Date |
Overview
Terumo Corporation, headquartered in Tokyo, Japan, is a globally recognized company in the medical product and equipment manufacturing sector. Its operations span across various continents including Japan, Europe, China, the United States, and other parts of Asia. The company's history dates back to 1921, initially founded as Sekisen Ken-onki Corporation before adopting its current name in October 1974. Terumo's business activities are organized into three main segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company, each focusing on distinct medical technologies and solutions aimed at improving patient care and medical outcomes.
Products and Services
- Cardiac and Vascular Company:
Offers a wide range of products for cardiology and endovascular therapies, including angiographic guidewires, catheters, introducer sheaths, vascular closure devices, and stents. Their portfolio extends to devices for treating cerebral aneurysm (coils, stents, and intrasaccular devices), embolization systems, aspiration catheters, and clot retrievers for ischemic stroke. They also produce oxygenators, cardio-pulmonary bypass systems, and artificial vascular and stent grafts.
- Medical Care Solutions Company:
Provides products aimed at general medical care such as syringes, infusion and syringe pumps, infusion lines, and IV solutions. Their offerings include peritoneal dialysis fluids, pain management, and nutritious food products. Additionally, they provide blood glucose monitoring systems, disposable needles for pen injectors, insulin patch pumps, blood pressure monitors, and digital thermometers. Terumo also engages in contract manufacturing of prefilled syringes and needles for pharmaceutical packaging.
- Blood and Cell Technologies Company:
Specializes in products for blood management and cellular technologies, including blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, and centrifugal apheresis systems. They also offer solutions for cell expansion, supporting advanced therapies and research in the life sciences sector.
